S. Tong, J. Davis, E. Eichenberger, T. Holland, and V. Fowler, Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management, Clinical Microbiology Reviews, vol.28, issue.3, p.60361, 2015.
DOI : 10.1128/CMR.00134-14

URL : http://cmr.asm.org/content/28/3/603.full.pdf

C. Selton-suty, M. Célard, L. Moing, V. Doco-lecompte, T. Chirouze et al., Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey, Clinical Infectious Diseases, vol.54, issue.9, p.12309, 2012.
DOI : 10.1093/cid/cis199

URL : https://hal.archives-ouvertes.fr/hal-00825451

W. Wilson, K. Taubert, M. Gewitz, P. Lockhart, L. Baddour et al., Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 9 oct, p.173654, 2007.

. Antibacterial-prophylaxis-for-dental and G. Gi, Med Lett Drugs Ther, p.5960, 1213.

G. Habib, P. Lancellotti, M. Antunes, M. Bongiorni, J. Casalta et al., 2015 ESC Guidelines for the management of infective endocarditis, Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 21 nov, p.3075128, 2015.
DOI : 10.1093/eurheartj/ehv319

URL : https://hal.archives-ouvertes.fr/hal-01466878

L. Slipczuk, J. Codolosa, C. Davila, A. Romero-corral, J. Yun et al., Infective Endocarditis Epidemiology Over Five Decades: A Systematic Review Disponible sur, PLoS ONE, vol.8, issue.12
DOI : 10.1371/journal.pone.0082665

URL : https://doi.org/10.1371/journal.pone.0082665

D. Murdoch, G. Corey, B. Hoen, J. Miró, V. Fowler et al., Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century, Archives of Internal Medicine, vol.169, issue.5, p.46373, 2009.
DOI : 10.1001/archinternmed.2008.603

URL : https://hal.archives-ouvertes.fr/hal-00464774

A. Bannay, B. Hoen, X. Duval, J. Obadia, C. Selton-suty et al., The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results?, European Heart Journal, vol.32, issue.16, 2011.
DOI : 10.1093/eurheartj/ehp008

URL : https://hal.archives-ouvertes.fr/hal-00733918

X. Duval, F. Delahaye, A. F. Tattevin, P. Obadia, J. et al., Temporal Trends in Infective Endocarditis in the Context of Prophylaxis Guideline Modifications, Journal of the American College of Cardiology, vol.59, issue.22, p.196876, 2012.
DOI : 10.1016/j.jacc.2012.02.029

URL : https://hal.archives-ouvertes.fr/hal-00825449

G. Habib, B. Hoen, P. Tornos, F. Thuny, B. Prendergast et al., Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer, Eur Heart J. oct, vol.30, p.2369413, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00465409

P. Moreillon and Y. Que, Infective endocarditis. The Lancet. 10 janv, p.13949, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00465409

I. Tleyjeh, A. Latif, H. Rahbi, C. Scott, K. Bailey et al., A Systematic Review of Population-Based Studies of Infective Endocarditis, Chest, vol.132, issue.3, p.102535, 2007.
DOI : 10.1378/chest.06-2048

C. Cabell, J. Jollis, G. Peterson, G. Corey, D. Anderson et al., Changing Patient Characteristics and the Effect on Mortality in Endocarditis, Archives of Internal Medicine, vol.162, issue.1, p.904, 2002.
DOI : 10.1001/archinte.162.1.90

G. Nadji, J. Rémadi, F. Coviaux, A. Mirode, A. Brahim et al., Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens, Heart, vol.91, issue.7, p.9327, 2005.
DOI : 10.1136/hrt.2004.042648

K. Werdan, S. Dietz, B. Löffler, S. Niemann, H. Bushnaq et al., Mechanisms of infective endocarditis: pathogen???host interaction and risk states, Nature Reviews Cardiology, vol.89, issue.1, p.3550, 2014.
DOI : 10.1161/CIRCULATIONAHA.108.773598

L. Loir, Y. Gautier, and M. , Staphylococcus aureus. Editions Médicales internationales, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01454440

B. Shenkman, D. Varon, I. Tamarin, R. Dardik, M. Peisachov et al., Role of agr (RNAIII) in Staphylococcus aureus adherence to fibrinogen, fibronectin, platelets and endothelial cells under static and flow conditions, Journal of Medical Microbiology, vol.51, issue.9, p.74754, 2002.
DOI : 10.1099/0022-1317-51-9-747

A. Toledo-arana, N. Merino, M. Vergara-irigaray, M. Débarbouillé, J. Penadés et al., Staphylococcus aureus Develops an Alternative, ica-Independent Biofilm in the Absence of the arlRS Two-Component System, Journal of Bacteriology, vol.187, issue.15, p.531829, 2005.
DOI : 10.1128/JB.187.15.5318-5329.2005

A. Millaire, E. Van-belle, P. De-groote, O. Leroy, and G. Ducloux, Obstruction of the Left Main Coronary Ostium Due to an Aortic Vegetation: Survival After Early Surgery, Clinical Infectious Diseases, vol.22, issue.1, p.1923, 1996.
DOI : 10.1093/clinids/22.1.192

B. Omari, S. Shapiro, L. Ginzton, J. Robertson, J. Ward et al., Predictive risk factors for periannular extension of native valve endocarditis. Clinical and echocardiographic analyses, Chest. déc, vol.96, issue.6, p.12739, 1989.

F. Thuny, D. Salvo, G. Disalvo, G. Belliard, O. Avierinos et al., Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study, Circulation. 5 juill, vol.112, issue.1, p.6975, 2005.

U. Snygg-martin, L. Gustafsson, L. Rosengren, A. Alsiö, P. Ackerholm et al., Cerebrovascular Complications in Patients with Left???Sided Infective Endocarditis Are Common: A Prospective Study Using Magnetic Resonance Imaging and Neurochemical Brain Damage Markers, Clinical Infectious Diseases, vol.47, issue.1, p.2330, 2008.
DOI : 10.1086/588663

E. García-cabrera, N. Fernández-hidalgo, B. Almirante, R. Ivanova-georgieva, M. Noureddine et al., Neurological Complications of Infective Endocarditis: Risk Factors, Outcome, and Impact of Cardiac Surgery: A Multicenter Observational Study, Circulation, vol.127, issue.23, p.227284, 2013.
DOI : 10.1161/CIRCULATIONAHA.112.000813

H. Jones and R. Siekert, Neurological manifestations of infective endocarditis. Review of clinical and therapeutic challenges, Brain J Neurol. oct, vol.112, p.1295315, 1989.

C. Clawson and J. White, Platelet Interaction with Bacteria, Am J Pathol. nov, vol.65, issue.2, p.36780, 1971.

T. Pessi, V. Karhunen, P. Karjalainen, A. Ylitalo, J. Airaksinen et al., Bacterial signatures in thrombus aspirates of patients with myocardial infarction. Circulation, pp.121928-121929, 2013.

H. Hamzeh-cognasse, D. P. Chabert, A. Pozzetto, B. Cognasse, F. Garraud et al., Platelets and Infections ???????? Complex Interactions with Bacteria, Frontiers in Immunology, vol.14, issue.10????????12, 4341565.
DOI : 10.1038/ni.2631

URL : http://journal.frontiersin.org/article/10.3389/fimmu.2015.00082/pdf

C. Clawson, G. Rao, and J. White, Platelet interaction with bacteria. IV. Stimulation of the release reaction, Am J Pathol. nov, vol.81, issue.2, p.41120, 1975.

C. Clawson and J. White, Platelet interaction with bacteria. V. Ultrastructure of congenital afibrinogenemic platelets, Am J Pathol. janv, vol.98, issue.1, 1980.

T. Youssefian, A. Drouin, J. Massé, J. Guichard, and E. Cramer, Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation, Blood, vol.99, issue.11, p.40219, 2002.
DOI : 10.1182/blood-2001-12-0191

X. Li, T. Iwai, H. Nakamura, Y. Inoue, Y. Chen et al., An ultrastructural study of Porphyromonas gingivalis-induced platelet aggregation, Thrombosis Research, vol.122, issue.6, p.8109, 2008.
DOI : 10.1016/j.thromres.2008.03.011

S. Kerrigan, N. Clarke, A. Loughman, G. Meade, T. Foster et al., Molecular Basis for Staphylococcus aureus-Mediated Platelet Aggregate Formation Under Arterial Shear In Vitro, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.2, p.33540, 2008.
DOI : 10.1161/ATVBAHA.107.152058

J. Fitzgerald, A. Loughman, F. Keane, M. Brennan, M. Knobel et al., Fibronectinbinding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor, Mol Microbiol. janv, vol.59, issue.1, p.21230, 2006.

H. Miajlovic, M. Zapotoczna, J. Geoghegan, S. Kerrigan, P. Speziale et al., Direct interaction of iron-regulated surface determinant IsdB of Staphylococcus aureus with the GPIIb/IIIa receptor on platelets, Microbiology, vol.156, issue.3, p.9208, 2010.
DOI : 10.1099/mic.0.036673-0

I. Siboo, H. Chambers, and P. Sullam, Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in Binding to Human Platelets, Infection and Immunity, vol.73, issue.4, p.227380, 2005.
DOI : 10.1128/IAI.73.4.2273-2280.2005

C. Garciarena, T. Mchale, R. Watkin, and S. Kerrigan, Coordinated Molecular Cross-Talk between Staphylococcus aureus, Endothelial Cells and Platelets in Bloodstream Infection, Pathogens, vol.83, issue.4, p.86982
DOI : 10.4049/jimmunol.173.2.1258

URL : http://www.mdpi.com/2076-0817/4/4/869/pdf

J. Hawiger, S. Steckley, D. Hammond, C. Cheng, S. Timmons et al., Staphylococciinduced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor, J Clin Invest. oct, vol.64, issue.4, p.9317, 1979.
DOI : 10.1172/jci109559

URL : http://www.jci.org/articles/view/109559/files/pdf

O. 'brien, L. Kerrigan, S. Kaw, G. Hogan, M. Penadés et al., Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A

O. Seaghdha, M. Van-schooten, C. Kerrigan, S. Emsley, J. Silverman et al., Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions, FEBS J. nov, vol.273, issue.21, p.483141, 2006.

S. Kerrigan and D. Cox, Platelet???bacterial interactions, Cellular and Molecular Life Sciences, vol.99, issue.Suppl 1, p.51323, 2010.
DOI : 10.1111/j.1538-7836.2007.02867.x

S. Bhakdi and J. Tranum-jensen, Alpha-toxin of Staphylococcus aureus, Microbiol Rev. déc, vol.55, issue.4, p.73351, 1991.

D. Cox, S. Kerrigan, and S. Watson, Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation, Journal of Thrombosis and Haemostasis, vol.7, issue.6, p.1097107, 2011.
DOI : 10.1111/j.1538-7836.2008.03211.x

H. Hu, P. Armstrong, E. Khalil, Y. Chen, A. Straub et al., GPVI and GPIb?? Mediate Staphylococcal Superantigen-Like Protein 5 (SSL5) Induced Platelet Activation and Direct toward Glycans as Potential Inhibitors, PLoS ONE, vol.77, issue.4
DOI : 10.1371/journal.pone.0019190.s001

URL : https://doi.org/10.1371/journal.pone.0019190

A. Verschoor and H. Langer, Crosstalk between platelets and the complement system in immune protection and disease, Thrombosis and Haemostasis, vol.110, issue.5, p.9109, 2013.
DOI : 10.1160/TH13-02-0102

L. Cosgrove, A. Dapice, A. Haddad, J. Pedersen, and I. Mckenzie, Immunology and Cell Biology -Abstract of article: CR3 receptor on platelets and its role in the prostaglandin metabolic pathway, Immunol Cell Biol. déc, vol.65, issue.6, p.45360, 1987.

E. Peerschke and B. Ghebrehiwet, Human blood platelet gC1qR/p33, Immunological Reviews, vol.180, issue.1, p.5664, 2001.
DOI : 10.1034/j.1600-065X.2001.1800105.x

M. Polley and R. Nachman, Human platelet activation by C3a and C3a des-arg, Journal of Experimental Medicine, vol.158, issue.2, p.60315, 1983.
DOI : 10.1084/jem.158.2.603

URL : http://jem.rupress.org/content/jem/158/2/603.full.pdf

H. Miajlovic, A. Loughman, M. Brennan, D. Cox, and T. Foster, Both Complement- and Fibrinogen-Dependent Mechanisms Contribute to Platelet Aggregation Mediated by Staphylococcus aureus Clumping Factor B, Infection and Immunity, vol.75, issue.7, p.333543, 2007.
DOI : 10.1128/IAI.01993-06

URL : http://iai.asm.org/content/75/7/3335.full.pdf

A. Loughman, J. Fitzgerald, M. Brennan, J. Higgins, R. Downer et al., Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A, Molecular Microbiology, vol.432, issue.3, p.80418, 2005.
DOI : 10.1111/j.1365-2672.1993.tb05195.x

T. Nguyen, B. Ghebrehiwet, and E. Peerschke, Staphylococcus aureus Protein A Recognizes Platelet gC1qR/p33: a Novel Mechanism for Staphylococcal Interactions with Platelets, Infection and Immunity, vol.68, issue.4, p.20618, 2000.
DOI : 10.1128/IAI.68.4.2061-2068.2000

E. Peerschke, T. Murphy, and B. Ghebrehiwet, Activation-dependent surface expression of gC1qR/p33 on human blood platelets, Thromb Haemost. févr, vol.89, issue.2, p.3319, 2003.

M. Yeaman, Platelets in defense against bacterial pathogens, Cellular and Molecular Life Sciences, vol.113, issue.Suppl 6B, p.52544, 2010.
DOI : 10.1093/infdis/168.4.910

URL : https://link.springer.com/content/pdf/10.1007%2Fs00018-009-0210-4.pdf

M. Yeaman, Y. Tang, A. Shen, A. Bayer, and M. Selsted, Purification and in vitro activities of rabbit platelet microbicidal proteins, Infect Immun. mars, vol.65, issue.3, p.102331, 1997.

A. Bayer, M. Ramos, B. Menzies, M. Yeaman, A. Shen et al., Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins, Infect Immun. nov, vol.65, issue.11, p.465260, 1997.

N. Azizi, Staphylococcus aureus elicits release of platelet microbicidal proteins in vitro, 1996.

R. Mercier, M. Rybak, A. Bayer, and M. Yeaman, Influence of Platelets and Platelet Microbicidal Protein Susceptibility on the Fate of Staphylococcus aureus in an In Vitro Model of Infective Endocarditis, Infection and Immunity, vol.68, issue.8, p.4699705, 2000.
DOI : 10.1128/IAI.68.8.4699-4705.2000

T. Wu, M. Yeaman, and A. Bayer, In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates., Antimicrobial Agents and Chemotherapy, vol.38, issue.4, p.72932, 1994.
DOI : 10.1128/AAC.38.4.729

V. Fowler, L. Mcintyre, M. Yeaman, G. Peterson, B. Reller et al., In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source, J Infect Dis. oct, vol.182, issue.4, p.12514, 2000.

L. Kupferwasser, M. Yeaman, S. Shapiro, C. Nast, and A. Bayer, In Vitro Susceptibility to Thrombin-Induced Platelet Microbicidal Protein Is Associated With Reduced Disease Progression and Complication Rates in Experimental Staphylococcus aureus Endocarditis, Circulation. 12 févr, vol.105, issue.6, p.74652, 2002.

C. Liu, T. Huang, P. Tsai, P. Tsai, L. Chang et al., A segment of Staphylococcus aureus clumping factor A with fibrinogen-binding activity (ClfA221???550) inhibits platelet-plug formation in mice, Thrombosis Research, vol.121, issue.2, p.18391, 2007.
DOI : 10.1016/j.thromres.2007.03.019

D. Nicolau, C. Freeman, C. Nightingale, R. Quintiliani, C. Coe et al., Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis, Infect Immun. avr, vol.61, issue.4, p.15935, 1993.

D. Nicolau, M. Marangos, C. Nightingale, and R. Quintiliani, Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis, Antimicrobial Agents and Chemotherapy, vol.39, issue.8, p.1748, 1995.
DOI : 10.1128/AAC.39.8.1748

D. Nicolau, P. Tessier, and C. Nightingale, Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis, International Journal of Antimicrobial Agents, vol.11, issue.2, p.15961, 1999.
DOI : 10.1016/S0924-8579(98)00092-2

T. Veloso, Y. Que, A. Chaouch, M. Giddey, J. Vouillamoz et al., Prophylaxis of Experimental Endocarditis With Antiplatelet and Antithrombin Agents: A Role for Long-term Prevention of Infective Endocarditis in Humans?, Journal of Infectious Diseases, vol.211, issue.1, p.729, 2015.
DOI : 10.1093/infdis/jiu426

T. Veloso, F. Oechslin, Y. Que, P. Moreillon, J. Entenza et al., Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus, 2017.
DOI : 10.1093/femspd/ftv060

URL : https://academic.oup.com/femspd/article-pdf/73/8/ftv060/10750045/ftv060.pdf

L. Kupferwasser, M. Yeaman, S. Shapiro, C. Nast, P. Sullam et al., Acetylsalicylic Acid Reduces Vegetation Bacterial Density, Hematogenous Bacterial Dissemination, and Frequency of Embolic Events in Experimental Staphylococcus aureus Endocarditis Through Antiplatelet and Antibacterial Effects, Circulation, vol.99, issue.21, p.27917, 1999.
DOI : 10.1161/01.CIR.99.21.2791

N. Anavekar, I. Tleyjeh, N. Anavekar, Z. Mirzoyev, J. Steckelberg et al., Impact of Prior Antiplatelet Therapy on Risk of Embolism in Infective Endocarditis, Clinical Infectious Diseases, vol.44, issue.9, p.11806, 2007.
DOI : 10.1086/513197

J. Pepin, V. Tremblay, D. Bechard, F. Rodier, C. Walker et al., Chronic antiplatelet therapy and mortality among patients with infective endocarditis, Clinical Microbiology and Infection, vol.15, issue.2, p.1939, 2009.
DOI : 10.1111/j.1469-0691.2008.02665.x

URL : https://doi.org/10.1111/j.1469-0691.2008.02665.x

D. Eisen, G. Corey, E. Mcbryde, V. Fowler, J. Miro et al., Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid, Journal of Infection, vol.58, issue.5, p.3328, 2009.
DOI : 10.1016/j.jinf.2009.03.006

N. Anavekar, J. Schultz, D. Sa, D. Thomas, J. Lahr et al., Modifiers of Symptomatic Embolic Risk in Infective Endocarditis, Mayo Clinic Proceedings, vol.86, issue.11, p.106874, 2011.
DOI : 10.4065/mcp.2011.0111

K. Chan, J. Tam, J. Dumesnil, B. Cujec, A. Sanfilippo et al., Effect of Long-Term Aspirin Use on Embolic Events in Infective Endocarditis, Clinical Infectious Diseases, vol.46, issue.1, p.3741, 2008.
DOI : 10.1086/524021

K. Chan, J. Dumesnil, B. Cujec, A. Sanfilippo, J. Jue et al., A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis, J Am Coll Cardiol. 3 sept, vol.42, issue.5, p.77580, 2003.

G. Habib and A. Cohen, Risque embolique des endocardites infectieuses. mt cardio. mai-juin, p.23542, 2005.

R. Sonneville, I. Klein, L. Bouadma, B. Mourvillier, B. Regnier et al., Complications neurologiques des endocardites infectieuses, Disponible sur, 2009.
DOI : 10.1016/j.reaurg.2009.06.010

E. Istvan and J. Deisenhofer, Structural Mechanism for Statin Inhibition of HMG-CoA Reductase, Science, vol.292, issue.5519, p.11604, 2001.
DOI : 10.1126/science.1059344

B. Kwak, F. Mulhaupt, S. Myit, and F. Mach, Statins as a newly recognized type of immunomodulator, Nat Med. déc, vol.6, issue.12, p.1399402, 2000.

D. Pruefer, R. Scalia, and A. Lefer, Simvastatin Inhibits Leukocyte-Endothelial Cell Interactions and Protects Against Inflammatory Processes in Normocholesterolemic Rats, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.19, issue.12, p.2894900, 1999.
DOI : 10.1161/01.ATV.19.12.2894

URL : http://atvb.ahajournals.org/content/atvbaha/19/12/2894.full.pdf

V. Serebruany, M. Miller, A. Pokov, A. Malinin, D. Lowry et al., Effect of Statins on Platelet PAR-1 Thrombin Receptor in Patients With the Metabolic Syndrome (From the PAR-1 Inhibition by Statins [PARIS] Study), The American Journal of Cardiology, vol.97, issue.9, p.13326, 2006.
DOI : 10.1016/j.amjcard.2005.11.058

M. Osthoff, J. Sidler, B. Lakatos, R. Frei, M. Dangel et al., Low-Dose Acetylsalicylic Acid Treatment and Impact on Short-Term Mortality in Staphylococcus aureus Bloodstream Infection, Critical Care Medicine, vol.44, issue.4, p.77381, 2016.
DOI : 10.1097/CCM.0000000000001554